eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community


All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms   -   Check drugs   -   Compare drugs   -   Join a support group   -   More tools

From FDA reports: drug interactions between Clonidine, Nasonex, Doxycycline, Hydralazine Hcl for a Male patient aged 50

This is a personalized study for a 50 year old male patient. The study is created by eHealthMe based on reports of 32 people who take the same drugs and have drug interactionsfrom FDA.

On Mar, 31, 2015: 32 people who reported to have interactions when taking Clonidine, Nasonex, Doxycycline, Hydralazine Hcl are studied

Trend of Clonidine, Nasonex, Doxycycline, Hydralazine Hcl's drug interactions, side effects, and effectiveness reports (7487991)

Information of the patient in this study:

Age: 50

Gender: male

Conditions: Hypertension

Drugs taking:
- Clonidine
- Nasonex
- Doxycycline
- Hydralazine Hcl: used for < 1 month

Drug interactions have: Arthralgia, Chills, Headache, Nausea, Photosensitivity Reaction, Pyrexia, Vomiting

eHealthMe real world results:

Comparison with this patient's adverse outcomes among males aged 50 (±5):

InteractionNumber of reports
Arthralgia1 (100.00%)
Chills1 (100.00%)
Headache1 (100.00%)
Nausea1 (100.00%)
Photosensitivity Reaction1 (100.00%)
Pyrexia1 (100.00%)
Vomiting1 (100.00%)

Most common interactions experienced by males aged 50 (±5) in the use of Clonidine, Nasonex, Doxycycline, Hydralazine Hcl:

InteractionNumber of reports
Headache1
Arthralgia1
Chills1
Nausea1
Vomiting1
Photosensitivity Reaction1
Pyrexia1

Most common interactions experienced by males aged 50 (±5) in long term use of Clonidine, Nasonex, Doxycycline, Hydralazine Hcl:

None.

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

InteractionNumber of reports
Arthralgia20 (62.50%)
Chills28 (87.50%)
Headache32 (100.00%)
Nausea18 (56.25%)
Photosensitivity Reaction2 (6.25%)
Pyrexia32 (100.00%)
Vomiting32 (100.00%)

Most common interactions experienced by people in the use of Clonidine, Nasonex, Doxycycline, Hydralazine Hcl:

InteractionNumber of reports
Vomiting32
Oedema Peripheral32
Anxiety32
Deformity32
Dyspnoea32
Pain32
Back Pain32
Spondylolisthesis32
Pyrexia32
Headache32

Most common interactions experienced by people in long term use of Clonidine, Nasonex, Doxycycline, Hydralazine Hcl:

None.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

 

 

 

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us - eHealth.me

 
© 2015 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.